ANTONIOTTI, CARLOTTA
 Distribuzione geografica
Continente #
NA - Nord America 738
EU - Europa 338
AS - Asia 178
SA - Sud America 22
AF - Africa 15
OC - Oceania 7
Totale 1.298
Nazione #
US - Stati Uniti d'America 720
IT - Italia 145
CN - Cina 66
DE - Germania 62
FR - Francia 51
JP - Giappone 25
IN - India 23
GB - Regno Unito 21
CA - Canada 15
SG - Singapore 14
VN - Vietnam 11
PS - Palestinian Territory 10
ES - Italia 9
KR - Corea 9
AU - Australia 7
BR - Brasile 7
NL - Olanda 7
CH - Svizzera 6
CO - Colombia 6
FI - Finlandia 6
ZA - Sudafrica 6
CL - Cile 5
IE - Irlanda 5
AT - Austria 4
RO - Romania 4
TR - Turchia 4
TW - Taiwan 4
CZ - Repubblica Ceca 3
DK - Danimarca 3
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
HK - Hong Kong 3
MX - Messico 3
RU - Federazione Russa 3
UG - Uganda 3
AR - Argentina 2
EC - Ecuador 2
LB - Libano 2
PL - Polonia 2
BD - Bangladesh 1
BE - Belgio 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
MY - Malesia 1
PK - Pakistan 1
PT - Portogallo 1
SI - Slovenia 1
TH - Thailandia 1
UA - Ucraina 1
Totale 1.298
Città #
Fairfield 68
Ashburn 58
Seattle 54
Woodbridge 49
Buffalo 48
Santa Cruz 48
Houston 35
Cambridge 28
Wilmington 22
Serra 18
Ann Arbor 17
Chicago 13
Fiume Veneto 11
Los Angeles 11
Rome 11
Shenyang 11
Las Vegas 10
Milan 10
Phoenix 10
Pisa 10
Clearwater 9
Dong Ket 9
Des Moines 8
Mountain View 8
Nürnberg 8
Paris 8
Beijing 7
Shanghai 7
Boston 6
Henderson 6
Muizenberg 6
Helsinki 5
Kolkata 5
Singapore 5
Taiyuan 5
Toronto 5
Boardman 4
Bogotá 4
De Bilt 4
Dublin 4
Icheon-si 4
Mumbai 4
Ottawa 4
Provo 4
Riva 4
Salisbury 4
Sydney 4
Tampa 4
Tokyo 4
University Park 4
Ankara 3
Bengaluru 3
Bochum 3
Falkenstein 3
Guangzhou 3
Herndon 3
London 3
Montereale Valcellina 3
New York 3
Palermo 3
Risch 3
San Francisco 3
Toulouse 3
Verona 3
Bath 2
Beirut 2
Berlin 2
Bristol 2
Cheyenne 2
Columbus 2
Copenhagen 2
Crewkerne 2
Dallas 2
Gáldar 2
Hacienda Ibarra 2
Innsbruck 2
Lake Forest 2
Leawood 2
Leeds 2
Melbourne 2
Milpitas 2
Montefalco 2
Nanded 2
Nanjing 2
Peccioli 2
Pittsburgh 2
Providence 2
Puig-reig 2
Pune 2
Rochester 2
Sanluri 2
Thornhill 2
Tianjin 2
Turin 2
Valencia 2
Vienna 2
Ōtemachi 2
Ahmedabad 1
Amsterdam 1
Annemasse 1
Totale 816
Nome #
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: Updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study, file e0d6c930-e9b0-fcf8-e053-d805fe0aa794 288
TRIPLETE: A randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer, file e0d6c92c-198b-fcf8-e053-d805fe0aa794 195
Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis, file e0d6c928-e9a1-fcf8-e053-d805fe0aa794 165
KRAS and BRAF genotyping of synchronous colorectal carcinomas., file e0d6c927-102d-fcf8-e053-d805fe0aa794 131
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab, file e0d6c92c-5637-fcf8-e053-d805fe0aa794 109
TRIBE-2: A phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group, file e0d6c92c-363a-fcf8-e053-d805fe0aa794 106
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab, file e0d6c92c-1e43-fcf8-e053-d805fe0aa794 103
Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib, file e0d6c927-46be-fcf8-e053-d805fe0aa794 91
Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study, file e0d6c930-d7c4-fcf8-e053-d805fe0aa794 55
FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies, file e0d6c931-b004-fcf8-e053-d805fe0aa794 26
Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability, file 291c71a9-3cd9-4916-a52b-547618d5e2eb 19
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer, file e0d6c930-66a6-fcf8-e053-d805fe0aa794 12
DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer, file e0d6c92a-065f-fcf8-e053-d805fe0aa794 11
Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials, file 198caa20-17dc-4428-a4ee-95bf6b386924 8
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan, file e0d6c926-4717-fcf8-e053-d805fe0aa794 5
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO, file 4870a7f6-1976-4e48-9a88-2922c6ef7a46 4
The winding roadmap of biomarkers toward clinic: Lessons from predictors of resistance to anti-EGFRs in metastatic colorectal cancer, file e0d6c92c-0285-fcf8-e053-d805fe0aa794 3
Primary Tumor Sidedness and Benefit from FOLFOXIRI plus Bevacizumab as Initial Therapy for Metastatic Colorectal Cancer, file e0d6c92f-d335-fcf8-e053-d805fe0aa794 3
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: Updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study, file 1761d038-570a-494e-8068-60f2f66b9017 2
Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials, file 7c089d77-1b68-4249-b00a-398f1db2875d 2
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study, file e0d6c92c-0d56-fcf8-e053-d805fe0aa794 2
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO, file e0d6c92f-97c3-fcf8-e053-d805fe0aa794 2
null, file e0d6c930-9f05-fcf8-e053-d805fe0aa794 2
null, file e0d6c930-b1b8-fcf8-e053-d805fe0aa794 2
Location of primary tumor and benefit from anti-epidermal growth factorreceptor monoclonalantibodies in patients with RAS and BRAF wild-typemetastatic colorectal cancer, file e0d6c930-c440-fcf8-e053-d805fe0aa794 2
NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients, file e0d6c92c-0f69-fcf8-e053-d805fe0aa794 1
Totale 1.349
Categoria #
all - tutte 2.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.596


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201938 0 0 0 0 0 0 0 0 0 0 16 22
2019/2020223 9 6 4 8 35 31 26 28 32 14 15 15
2020/2021221 23 29 9 12 13 22 15 21 25 20 17 15
2021/2022228 18 13 8 23 27 14 9 11 11 9 66 19
2022/2023193 4 12 53 36 30 18 5 7 2 5 19 2
2023/2024400 4 2 27 27 70 51 56 66 23 62 12 0
Totale 1.349